Roundhill GLP-1 & Weight Loss ETF (OZEM) in focus as Novo Nordisk drops on CagriSema phase 3 results vs Eli Lilly.
OZEM stock: What the Ratings say
Roundhill GLP-1 & Weight Loss ETF (OZEM) in focus as Novo Nordisk drops on CagriSema phase 3 results vs Eli Lilly.